110 related articles for article (PubMed ID: 3152943)
1. Human growth hormone (HGH) levels at diagnosis of acute lymphoblastic leukemia (ALL).
Rogers PC; Tze WJ; Chan KW; Teasdale JM
Pediatr Hematol Oncol; 1987; 4(4):353-6. PubMed ID: 3152943
[No Abstract] [Full Text] [Related]
2. Growth and Sm-C/IGF-I concentrations in children with acute leukemia (AL) and non-Hodgkin-lymphoma following cranial 60 cobalt or craniospinal gold (198 Au) irradiation.
Hesse V; Reska S; Fuchs D; Jahreis G; Zintl F
Padiatr Grenzgeb; 1990; 29(2):99. PubMed ID: 2352757
[No Abstract] [Full Text] [Related]
3. Prognostic value of plasma levels of thrombomodulin and von Willebrand factor in Egyptian children with acute lymphoblastic leukemia.
Hagag AA; Abdel-Lateef AE; Aly R
J Oncol Pharm Pract; 2014 Oct; 20(5):356-61. PubMed ID: 24243921
[TBL] [Abstract][Full Text] [Related]
4. Neonatal level of thyroid-stimulating hormone and acute childhood leukemia.
Lei U; Wohlfahrt J; Hjalgrim H; Hjalgrim LL; Simonsen H; Melbye M
Int J Cancer; 2000 Nov; 88(3):486-8. PubMed ID: 11054681
[TBL] [Abstract][Full Text] [Related]
5. Etiology of childhood leukemia: a possible alternative to the Greaves hypothesis.
Stewart A
Leuk Res; 1990; 14(11-12):937-9. PubMed ID: 2280607
[TBL] [Abstract][Full Text] [Related]
6. Human growth hormone and insulin-like growth factor-1 enhance the proliferation of human leukemic blasts.
Estrov Z; Meir R; Barak Y; Zaizov R; Zadik Z
J Clin Oncol; 1991 Mar; 9(3):394-9. PubMed ID: 1999709
[TBL] [Abstract][Full Text] [Related]
7. End of therapy minimal residual disease (MRD) measurement in children with ALL does not predict relapse.
Sarrawi TH; Zayyat I; Barakat F; Rezeq M; Jmaian SA; Madanat F
Hematol Oncol Stem Cell Ther; 2018 Mar; 11(1):41-43. PubMed ID: 28648946
[No Abstract] [Full Text] [Related]
8. Insulin-like growth factor system in Egyptian children with acute lymphoblastic leukemia.
Zakhary NI; Boshra SA; El-Sawalhi MM; Fahim AT; Ebeid EN
Genet Test Mol Biomarkers; 2012 Sep; 16(9):1067-72. PubMed ID: 22853046
[TBL] [Abstract][Full Text] [Related]
9. Value of flow cytometric analysis of peripheral blood samples in children diagnosed with acute lymphoblastic leukemia.
Lam G; Punnett A; Stephens D; Sung L; Abdelhaleem M; Hitzler J
Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28766841
[TBL] [Abstract][Full Text] [Related]
10. Correlation between high vascular endothelial growth factor-A serum levels and treatment outcome in patients with standard-risk acute lymphoblastic leukemia: a report from Children's Oncology Group Study CCG-1962.
Avramis IA; Panosyan EH; Dorey F; Holcenberg JS; Avramis VI;
Clin Cancer Res; 2006 Dec; 12(23):6978-84. PubMed ID: 17145817
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone provocation tests and their prediction in the growth of children treated for acute lymphoblastic leukemia.
Papadia C; Naves LA; Motta LD; Barboza Filho RF; Suzuki MT; Casulari LA
Minerva Endocrinol; 2006 Sep; 31(3):211-8. PubMed ID: 17213788
[TBL] [Abstract][Full Text] [Related]
12. High white cell count at presentation in children with acute lymphoblastic leukaemia.
Menon BS; Wan Maziah WM; Jackson N; Jamaluddin N; Narazah MY; Dasgupta A; Naing NN
Med J Malaysia; 1999 Jun; 54(2):283-4. PubMed ID: 10972046
[No Abstract] [Full Text] [Related]
13. Relationship of growth hormone deficiency and leukemia.
Rapaport R; Oberfield SE; Robison L; Salisbury S; David R; Rao J; Redmond GP
J Pediatr; 1995 May; 126(5 Pt 1):759-61. PubMed ID: 7752002
[TBL] [Abstract][Full Text] [Related]
14. Increased neonatal level of arginase 2 in cases of childhood acute lymphoblastic leukemia implicates immunosuppression in the etiology.
Nielsen AB; Zhou M; de Smith AJ; Wang R; McCoy L; Hansen H; Morimoto L; Grønbæk K; Johansen C; Kogan SC; Metayer C; Bracci PM; Ma X; Wiemels JL
Haematologica; 2019 Nov; 104(11):e514-e516. PubMed ID: 30923090
[No Abstract] [Full Text] [Related]
15. [The differential diagnosis of infectious mononucleosis and acute leukemia].
Zverkova AS; Trishkova LA; Faktorova EI
Vrach Delo; 1988 Oct; (10):31-3. PubMed ID: 3218192
[No Abstract] [Full Text] [Related]
16. Serum lipid alterations in acute lymphoblastic leukemia of childhood.
Moschovi M; Trimis G; Apostolakou F; Papassotiriou I; Tzortzatou-Stathopoulou F
J Pediatr Hematol Oncol; 2004 May; 26(5):289-93. PubMed ID: 15111780
[TBL] [Abstract][Full Text] [Related]
17. Does serum soluble vascular endothelial growth factor levels have different importance in pediatric acute leukemia and malignant lymphoma patients?
Dincaslan HU; Yavuz G; Unal E; Tacyildiz N; Ikinciogullari A; Dogu F; Guloglu D; Yuksek N; Ertem U
Pediatr Hematol Oncol; 2010 Oct; 27(7):503-16. PubMed ID: 20677920
[TBL] [Abstract][Full Text] [Related]
18. Cholesterol, lipoprotein and phospholipid levels in acute lymphoblastic leukaemia.
Shokumbi WA; Ahaneku JE; Okpala IE
Eur J Haematol; 1991 Jan; 46(1):59-61. PubMed ID: 1988313
[No Abstract] [Full Text] [Related]
19. Age distribution of childhood acute lymphoblastic leukemia cases suggests etiological clues.
Cocco P; Rapallo M; Biddau P; Murgia G; Targhetta R
Leukemia; 1996 Sep; 10(9):1558-9. PubMed ID: 8751481
[No Abstract] [Full Text] [Related]
20. CDKN2 deletions have no prognostic value in childhood precursor-B acute lymphoblastic leukaemia.
van Zutven LJ; van Drunen E; de Bont JM; Wattel MM; Den Boer ML; Pieters R; Hagemeijer A; Slater RM; Beverloo HB
Leukemia; 2005 Jul; 19(7):1281-4. PubMed ID: 15843818
[No Abstract] [Full Text] [Related]
[Next] [New Search]
